John T - Search Results

1

Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort.

Chia PL, Russell P, Asadi K, Thapa B, Gebski V, Murone C, Walkiewicz M, Eriksson U, Scott AM, John T. Chia PL, et al. Among authors: john t. Lung Cancer. 2020 Dec;150:1-8. doi: 10.1016/j.lungcan.2020.09.022. Epub 2020 Oct 1. Lung Cancer. 2020. PMID: 33035778

2

Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.

Russell PA, Barnett SA, Walkiewicz M, Wainer Z, Conron M, Wright GM, Gooi J, Knight S, Wynne R, Liew D, John T. Russell PA, et al. Among authors: john t. J Thorac Oncol. 2013 Apr;8(4):461-8. doi: 10.1097/JTO.0b013e3182828fb8. J Thorac Oncol. 2013. PMID: 23486266 Free article.

3

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

John T, Starmans MH, Chen YT, Russell PA, Barnett SA, White SC, Mitchell PL, Walkiewicz M, Azad A, Lambin P, Tsao MS, Deb S, Altorki N, Wright G, Knight S, Boutros PC, Cebon JS. John T, et al. PLoS One. 2013 Jul 23;8(7):e67876. doi: 10.1371/journal.pone.0067876. Print 2013. PLoS One. 2013. PMID: 23935846 Free PMC article.

4

A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.

Do H, Wong NC, Murone C, John T, Solomon B, Mitchell PL, Dobrovic A. Do H, et al. Among authors: john t. Sci Rep. 2014 Feb 26;4:4186. doi: 10.1038/srep04186. Sci Rep. 2014. PMID: 24569633 Free PMC article.

5

Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.

Wright GM, Do H, Weiss J, Alam NZ, Rathi V, Walkiewicz M, John T, Russell PA, Dobrovic A. Wright GM, et al. Among authors: john t. Oncotarget. 2014 Apr 30;5(8):2107-15. doi: 10.18632/oncotarget.1840. Oncotarget. 2014. PMID: 24742923 Free PMC article.

6

Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.

Chia PL, Mitchell P, Dobrovic A, John T. Chia PL, et al. Among authors: john t. Clin Epidemiol. 2014 Nov 20;6:423-32. doi: 10.2147/CLEP.S69718. eCollection 2014. Clin Epidemiol. 2014. PMID: 25429239 Free PMC article. Review.

7

Vortex Keratopathy Presumed Secondary to AZD9291.

Chia PL, John T. Chia PL, et al. Among authors: john t. J Thorac Oncol. 2015 Dec;10(12):1807-8. doi: 10.1097/JTO.0000000000000634. J Thorac Oncol. 2015. PMID: 26709481 Free article. No abstract available.

8

PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.

Ameratunga M, Asadi K, Lin X, Walkiewicz M, Murone C, Knight S, Mitchell P, Boutros P, John T. Ameratunga M, et al. Among authors: john t. PLoS One. 2016 Apr 22;11(4):e0153954. doi: 10.1371/journal.pone.0153954. eCollection 2016. PLoS One. 2016. PMID: 27104612 Free PMC article.

9

Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC).

Chia PL, John T. Chia PL, et al. Among authors: john t. J Immunother. 2016 Jun;39(5):202-4. doi: 10.1097/CJI.0000000000000121. J Immunother. 2016. PMID: 27163740

10

Current and Evolving Methods to Visualize Biological Data in Cancer Research.

Chia PL, Gedye C, Boutros PC, Wheatley-Price P, John T. Chia PL, et al. Among authors: john t. J Natl Cancer Inst. 2016 May 31;108(8):djw031. doi: 10.1093/jnci/djw031. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27245079 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,443 results

Search Page

Filters